GelNB molecular coating as a biophysical barrier to isolate intestinal irritating metabolites and regulate intestinal microbial homeostasis in the treatment of inflammatory bowel disease
Authors:
Open Access
- 21 April 2022
- journal article
- research article
- Published by KEAI Publishing in Bioactive Materials
- Vol. 19, 251-267
Abstract
Inflammatory bowel disease (IBD) is a chronic, immune-mediated inflammatory disease characterized by the destruction of the structure and function of the intestinal epithelial barrier. Due to the poor remission effect and severe adverse events associated with current clinical medications, IBD remains an incurable disease. Here, we demonstrated a novel treatment strategy with high safety and effective inflammation remission via tissue-adhesive molecular coating. The molecular coating is composed of o-nitrobenzaldehyde (NB)-modified Gelatin (GelNB), which can strongly bond with –NH2 on the intestinal surface of tissue to form a thin biophysical barrier. We found that this molecular coating was able to stay on the surface of the intestine for long periods of time, effectively protecting the damaged intestinal epithelium from irritations of external intestinal metabolites and harmful flora. In addition, our results showed that this coating not only provided a beneficial environment for cell migration and proliferation to promote intestinal repair and regeneration, but also achieved a better outcome of IBD by reducing intestinal inflammation. Moreover, the in vivo experiments showed that the GelNB was better than the classic clinical medication—mesalazine. Therefore, our molecular coating showed potential as a promising strategy for the prevention and treatment of IBD.Keywords
Funding Information
- Zhejiang Province Natural Science Foundation
This publication has 86 references indexed in Scilit:
- Vedolizumab as Induction and Maintenance Therapy for Crohn's DiseaseNew England Journal of Medicine, 2013
- Poly--Glutamic Acid Attenuates Angiogenesis and Inflammation in Experimental ColitisMediators of Inflammation, 2013
- Adjuvant Activity of Sargassum pallidum Polysaccharides against Combined Newcastle Disease, Infectious Bronchitis and Avian Influenza Inactivated VaccinesMarine Drugs, 2012
- Animal Protein Intake and Risk of Inflammatory Bowel Disease: The E3N Prospective StudyAmerican Journal of Gastroenterology, 2010
- The Mongolian gerbil as a model for inflammatory bowel diseaseInternational Journal of Experimental Pathology, 2010
- Infliximab, Azathioprine, or Combination Therapy for Crohn's DiseaseNew England Journal of Medicine, 2010
- Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCRFEMS Microbiology Ecology, 2009
- RGD modified PLGA/gelatin microspheres as microcarriers for chondrocyte deliveryJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2009
- Adenosine: An immune modulator of inflammatory bowel diseasesWorld Journal of Gastroenterology, 2009
- Antibodies to interleukin 12 abrogate established experimental colitis in mice.Journal of Experimental Medicine, 1995